NCT07118735View on ClinicalTrials.gov

AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy

NANot yet recruitingINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

August 20, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2028

Conditions
Liver CancerHepatocellular Carcinoma
Interventions
DIETARY_SUPPLEMENT

A standardized extract of cultured Lentinula edodes mycelia (AHCC®)

3 grams of AHCC® taken orally once daily for 6 months or until disease progression or intolerance

DIETARY_SUPPLEMENT

Placebo

3 grams of dextrin (placebo) taken orally once daily for 6 months or until disease progression or intolerance

Trial Locations (1)

704

No. 138, Shengli Rd., North Dist, Tainan City

All Listed Sponsors
lead

National Cheng-Kung University Hospital

OTHER